JCU (4975) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
10 Dec, 2025Executive summary
Net sales for 1Q FY3/26 reached ¥7,037 million, a 19.0% increase year-over-year.
Operating profit rose 40.4% to ¥2,802 million compared to the same quarter last year.
Ordinary profit for the quarter was ¥2,845 million, up 27.2% year-over-year.
Profit attributable to owners of parent grew 61.7% year-over-year to ¥2,237 million.
Financial highlights
Net income per share for 1Q FY3/26 was 81.25 yen, up from 59.55 yen in the prior year.
Gross profit and higher sales of chemicals were key contributors to profit growth.
Comprehensive income for the quarter was ¥715 million, down 70.9% year-over-year.
Total assets as of June 30, 2025, were ¥52,367 million, with net assets of ¥47,556 million.
Capital adequacy ratio improved to 90.8% from 87.2% at the previous fiscal year-end.
Outlook and guidance
Full-year FY3/26 forecasts: net sales ¥28,500 million, operating profit ¥10,700 million, ordinary profit ¥10,800 million, profit attributable to owners of parent ¥7,400 million.
1Q results represent 24.7% to 27.4% progress toward full-year targets.
Net income per share forecasted at 296.94 yen for the full year.
Interim and year-end dividends are forecast at ¥41.00 each, totaling ¥82.00 for the year.
Full-year net sales forecast is a 0.5% increase year-over-year, with operating profit up 1.8% and profit attributable to owners down 1.3%.
Latest events from JCU
- Profits and sales rose, with higher full-year and dividend forecasts.4975
Q3 20265 Feb 2026 - Strong profit and sales growth, share buyback, and positive full-year outlook.4975
Q1 202510 Dec 2025 - Profits and sales soared on electronics recovery, with robust cash flow and a positive outlook.4975
Q2 202510 Dec 2025 - Profits and sales soared on Asian electronics recovery, prompting an upward outlook revision.4975
Q3 202510 Dec 2025 - Double-digit profit growth, higher dividends, and stable FY2026 outlook with currency risk.4975
Q4 202510 Dec 2025 - Strong 1H FY3/26 growth in sales and profit, with positive outlook and higher dividends.4975
Q2 202610 Dec 2025